Pilot Study Evaluating Pharmacokinetic Parameters of Capecitabine Dosing in Patients With Advanced Cancer and Elevated Body Mass Index
Phase of Trial: Phase IV
Latest Information Update: 21 May 2018
At a glance
- Drugs Capecitabine (Primary)
- Indications Obesity; Solid tumours
- Focus Pharmacokinetics
- 07 May 2018 Status changed from recruiting to completed.
- 30 Jan 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 30 Jan 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.